- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Breast Cancer Patients in Argentina
Total 509 results
-
Hospital Italiano de Buenos AiresDuke UniversityUnknown
-
Latin American & Caribbean Society of Medical OncologyBreast Cancer Research FoundationUnknown
-
Laboratorio Elea Phoenix S.A.Completed
-
PfizerCompletedBreast Cancer MetastaticArgentina, United Kingdom
-
Hospital Militar Central Cirujano Mayor Dr. Cosme...Instituto Nacional del Cáncer, ArgentinaRecruiting
-
Hospital Italiano de Buenos AiresRecruitingReminder Systems | No-Show PatientsArgentina
-
Hospital Provincial Magdalena V. de MartínezNational Agency for Scientific and Technological Promotion, Argentina; Instituto...Completed
-
Hoffmann-La RocheCompletedBreast CancerArgentina
-
Gema Biotech S.A.QUID Quality in Drugs and Devices Latin American Consulting SRLUnknown
-
Daiichi Sankyo, Inc.TerminatedMetastatic Breast CancerChile, Argentina
-
Centro Oncologico de ExcelenciaUnknownBreast Cancer | Colorectal Cancer | Melanoma (Skin)Argentina
-
Mast Therapeutics, Inc.UnknownBreast CancerArgentina, Mexico, Peru, Russian Federation, Spain
-
National Cancer Institute (NCI)CompletedBreast CancerMexico, Argentina, Brazil, Chile, Uruguay
-
Fundación HuéspedPfizerUnknownAIDS | HIV-1 Adults Patients | Triple Class FailureArgentina
-
Grupo Oncologico Cooperativo del SurSuspended
-
Instituto de Investigacion Sanitaria La FeKarolinska Institutet; Medical University of Vienna; Ain Shams University; Medical... and other collaboratorsRecruitingBreast CancerAustria, Sweden, Turkey, Argentina, Croatia, Egypt, Poland, Spain
-
Hoffmann-La RocheCompletedBreast CancerArgentina
-
Bristol-Myers SquibbCompletedBreast CancerUnited States, Peru, Argentina, Mexico
-
Grupo Oncologico Cooperativo del SurUnknownBreast CancerArgentina, Mexico
-
PfizerCompletedAdvanced Breast Cancer FemaleMexico, Argentina, Brazil, Colombia
-
Centro de Estudios en Genetica y ReproduccionNot yet recruitingPatient Satisfaction | Test Anxiety | Music | Embryo Transfer | REPRODUCTIVE TECHNIQUESArgentina
-
Centro de Estudio de Estado y SociedadDana-Farber Cancer Institute; Deakin UniversityCompleted
-
Novartis PharmaceuticalsCompletedTriple-negative Breast CancerBelgium, Italy, Japan, Taiwan, United States, Australia, Singapore, Spain, Germany, Korea, Republic of, Argentina, Canada, France, Hungary, Israel, Lebanon, Thailand
-
Hoffmann-La RocheActive, not recruitingInflammatory Breast Cancer | Early Breast Cancer | Locally Advanced Breast CancerCanada, Croatia, Spain, Argentina, Mexico, Korea, Republic of, Bosnia and Herzegovina, Brazil, Costa Rica, Turkey, Singapore, Bulgaria, South Africa, India, Peru, Kenya, Chile
-
Synta Pharmaceuticals Corp.CompletedBreast Cancer | Triple Negative Breast Cancer | HER-2 Positive Breast Cancer | ER/Progressive Response (PR) + Refractory to Prior Hormonal TreatmentSpain, United States, Argentina, Belgium, Brazil, Korea, Republic of, Peru, United Kingdom
-
University Hospital, Basel, SwitzerlandSwiss National Science Foundation; Krebsforschung Schweiz, Bern, Switzerland; Rising Tide FoundationRecruitingLymphedema, Breast CancerSpain, Switzerland, United States, Germany, Argentina, Austria, Belgium, Brazil, Canada, Greece, Italy, Netherlands, Romania, Sweden
-
University Hospital, Basel, SwitzerlandETOP IBCSG Partners Foundation; Austrian Breast Cancer Study GroupRecruitingNode-positive Breast CancerGreece, Switzerland, Hungary, Austria, Germany, Italy, Lithuania, Argentina, Croatia
-
Athenex, Inc.CompletedMetastatic Breast CancerArgentina, Chile, Colombia, Dominican Republic, Ecuador, El Salvador, Guatemala, Honduras, Panama, Peru
-
Olema Pharmaceuticals, Inc.RecruitingBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | HER2 Negative Breast Carcinoma | ER Positive Breast CancerUnited States, Korea, Republic of, Australia, Taiwan, Hong Kong, Malaysia, Thailand, Argentina, Belgium, Portugal, Italy
-
AstraZenecaCompleted
-
Eli Lilly and CompanyCompletedBreast CancerArgentina, Belgium, Germany, Romania, Spain, United Kingdom
-
SanofiCompletedBreast CancerUnited States, France, Canada, Germany, Italy, Netherlands, Spain, Switzerland, Turkey, Belgium, Argentina, Denmark, Colombia, Korea, Republic of, South Africa
-
American College of Radiology Imaging NetworkNational Cancer Institute (NCI)CompletedBreast CancerUnited States, Canada, Argentina
-
AstraZenecaCompletedStable COPD PatientsMexico, Chile, Argentina, Colombia, Costa Rica, Uruguay
-
Hoffmann-La RocheActive, not recruitingTriple-Negative Breast CancerItaly, Portugal, Slovenia, Spain, Romania, France, Czechia, Peru, Argentina, Chile, Hungary, Mexico, Poland
-
PfizerRecruitingAdvanced or Metastatic Breast CancerUnited States, Israel, Taiwan, Argentina, Japan, Korea, Republic of, Canada, Australia, Brazil
-
Eli Lilly and CompanyTerminatedBreast CancerMexico, France, Australia, Argentina, South Africa
-
Hoffmann-La RocheCompletedHER2-Positive Early Breast CancerUnited States, Finland, Hong Kong, Panama, Portugal, Spain, Mexico, Sweden, Brazil, Serbia, Argentina, Lebanon, Cuba, Qatar, Saudi Arabia, Chile, Jordan
-
Eli Lilly and CompanyCompletedHER-2 Positive Breast Cancer | Hormone Receptor Positive Breast CancerSpain, United States, Korea, Republic of, Belgium, France, Germany, Italy, Australia, Argentina, Canada, United Kingdom, Mexico, Brazil, Greece
-
SanofiCancer International Research Group (CIRG)CompletedBreast CancerUnited States, France, Canada, Brazil, Poland, Germany, Portugal, Spain, Sweden, Slovakia, Czech Republic, Uruguay, Argentina, Egypt, Hungary, Israel, South Africa, Austria, Greece, United Kingdom
-
Bristol-Myers SquibbCompletedBreast Cancer | MetastasisUnited States, Spain, Belgium, Peru, Italy, Argentina, France
-
Hoffmann-La RocheLatin American Cooperative Oncology GroupActive, not recruitingBreast CancerColombia, Guatemala, Argentina, Brazil, Chile, Cuba, Mexico, Peru, Uruguay, Dominican Republic
-
Eli Lilly and CompanyCompletedBreast CancerArgentina, Belgium, Brazil, Mexico, Portugal
-
Novartis PharmaceuticalsCompletedHormone Receptor Positive Breast CancerUnited States, Argentina, Thailand, Japan, France, Korea, Republic of, Spain, Turkey, Hungary, United Kingdom, Portugal, Brazil, Netherlands
-
Novartis PharmaceuticalsRecruitingMetastatic Breast CancerUnited States, Lebanon, Hong Kong, Turkey, Vietnam, Brazil, Italy, South Africa, Korea, Republic of, Poland, Taiwan, Singapore, Japan, Spain, Costa Rica, Greece, Portugal, Argentina, Mexico
-
Eli Lilly and CompanyCompletedBreast Cancer | Breast Neoplasms | Cancer of the BreastUnited States, Argentina, Australia, Brazil, Korea, Republic of, Mexico, Puerto Rico, Taiwan
-
Hoffmann-La RocheCompletedTriple-Negative Breast CancerFrance, Canada, Israel, Italy, Argentina, Brazil, China, Croatia, Germany, Greece, Slovakia, Turkey, Saudi Arabia, Japan, India, Spain, United States, Czechia, Romania, United Kingdom, Morocco, South Africa, Vietnam, Russian Federation
-
Eli Lilly and CompanyActive, not recruitingMetastatic Breast CancerSpain, Taiwan, United States, Italy, Czechia, Germany, Belgium, Turkey, Brazil, Russian Federation, Argentina, Austria, France, Mexico
-
Hoffmann-La RocheRecruitingBreast CancerKorea, Republic of, United States, Israel, Denmark, Argentina, Mexico, Brazil, Germany, Peru, Poland, Spain, Taiwan, South Africa, Czechia, Australia
-
Hoffmann-La RocheCompletedEarly Breast CancerFrance, Spain, United States, Korea, Republic of, Canada, United Kingdom, Argentina, Belgium, Germany, Italy, Taiwan, Thailand, Japan, Brazil, Mexico, Czechia, Poland, Russian Federation, Ukraine